Envoy Medical draws $2.5M under note from GAT Funding; issues warrant for 250K shares

Envoy Medical, Inc.

Drew $2.5M from GAT Funding LLC (controlled by director Glen Taylor); aggregate $7.5M of $10M max.
Issued warrant to purchase 250K shares of Class A common at $3.04 (closing price), expiring Feb 27, 2026.
Warrant serves as commitment fee for the draw; unregistered, exempt under Section 4(a)(2)/Reg D.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.